Monty Rakusen Investment summary My previous investment thought on Marvell Technology (NASDAQ:MRVL) (published in April 2024) was a buy rating because of my belief that the worst was over, and the business should start to see growth recovery in 2H25. I reiterate a buy rating for MRVL, as the path to an upcycle has become more visible after looking at the 1Q25 results. Management guidance and forward-looking comments were also very encouraging. There are also visible catalysts that suggest growth could furth ...